Research Reports

[2021] Digital Breast Tomosynthesis Equipment Market Share Is Anticipated to touch US$ 4,212.4 Million By 2027

Published by Coherent Market Insights

Posted on September 17, 2021

3 min read

· Last updated: February 9, 2026

Add as preferred source on Google
Lawmaker Kim Leadbeater discusses UK's assisted dying law changes - Global Banking & Finance Review
Image of Kim Leadbeater addressing the media about proposed changes to the UK's assisted dying law, emphasizing the removal of High Court judge sign-off to enhance the legislative process.
Global Banking & Finance Awards 2026 — Call for Entries

Digital Breast Tomosynthesis (DBT) Equipment is a product advanced through a crew of breast augmentation medical doctors and technicians, with an purpose to offer sufferers with one of the maximum reliable, safest, and cost-powerful tactics to be had. As this innovative new breast enhancement process isn’t always to be had in each area, it is […]

[2021] Digital Breast Tomosynthesis Equipment Market Share Is Anticipated to ...

Digital Breast Tomosynthesis (DBT) Equipment is a product advanced through a crew of breast augmentation medical doctors and technicians, with an purpose to offer sufferers with one of the maximum reliable, safest, and cost-powerful tactics to be had. As this innovative new breast enhancement process isn’t always to be had in each area, it is able to be tough to discover the best device to fit your precise needs. Digital breast tomosynthesis device is designed to offer all-over development to the breasts in order that any female can get the appearance she needs with out incurring outrageous costs. DBT additionally called 3-D mammography, is likewise utilized by radiologists to diagnose breast cancer. It makes use of a chain of two-dimensional pictures to construct a 3-D photo of the breast.

Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/3445

Increasing prevalence of breast cancer is expected to drive growth of the global digital breast tomosynthesis equipment market during the forecast period. According to the World Cancer Research Fund, in 2018, there were over 2 million new cases of breast cancer across 25 countries in the world. According to the American Cancer Society, in 2020, around 276,480 new cases of invasive breast cancer are expected to be diagnosed in the U.S. in women with over 40,000 women dying from it. Such a massive prevalence of breast cancer has increased the demand for DBT equipment across the globe. Thus, these factors are expected to drive growth of the global digital breast tomosynthesis equipment market during the forecast period. Furthermore, rising awareness regarding the use of DBT equipment as well as technological advancements in the field of breast imaging is expected to propel the global digital breast tomosynthesis equipment market growth in the near future.

However, the high capital cost of the equipment combined with side-effects related to radiation exposure is expected to restrict growth of the global digital breast tomosynthesis equipment market during the forecast period. Furthermore, among regions, North America is expected to witness significant growth in the global digital breast tomosynthesis equipment market during the forecast period. This is owing to high demand for innovative products as well as the presence of skilled healthcare professionals in the region.

Key players involved in the global digital breast tomosynthesis equipment market are Hologic, Inc., Trivitron Healthcare, GE Healthcare, Analogic Corporation, Fujifilm Holdings Corporation, Planmed Oy, Siemens Healthineers, and General Medical Merate SpA.

For instance, in March 2020, Hologic Inc., a U.S.-based medical technology company, received the U.S. Food and Drug Administration (FDA) approval for its 3DQuorum Imaging Technology, which is powered by Genius AI.

Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/3445

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

The post [2021] Digital Breast Tomosynthesis Equipment Market Share Is Anticipated to touch US$ 4,212.4 Million By 2027 appeared first on Gatorledger.

Frequently Asked Questions

What is the projected market size for digital breast tomosynthesis equipment by 2027?
The digital breast tomosynthesis equipment market is anticipated to reach approximately US$ 4,212.4 million by 2027.
What factors are driving the growth of the digital breast tomosynthesis market?
The increasing prevalence of breast cancer is expected to drive growth in the global digital breast tomosynthesis equipment market.
Who are the key players in the digital breast tomosynthesis equipment market?
Key players include Hologic, Inc., Trivitron Healthcare, GE Healthcare, Analogic Corporation, and Fujifilm Holdings Corporation.
What challenges does the digital breast tomosynthesis market face?
The high capital cost of the equipment and side effects related to radiation exposure are expected to restrict market growth.
What recent advancements have been made in digital breast tomosynthesis technology?
In March 2020, Hologic Inc. received FDA approval for its 3DQuorum Imaging Technology, which enhances the capabilities of digital breast tomosynthesis.

Tags

Related Articles

More from Research Reports

Explore more articles in the Research Reports category